Integra LifeSciences / Codman Neurosurgery Business merger inquiry
The CMA investigated and cleared the anticipated acquisition by Integra LifeSciences Holdings Corporation of the Codman Neurosurgery Business.
Statutory timetable
| Phase 1 date | Action |
|---|---|
| 3 August 2017 | Decision published |
| 6 July 2017 | Decision announced |
| 26 May to 12 June 2017 | Invitation to comment |
| 26 May 2017 | Launch of merger inquiry |
Phase 1
CMA clearance decision
6 July 2017: The CMA has cleared the anticipated acquisition by Integra LifeSciences Holdings Corporation of the Codman Neurosurgery Business, using the 鈥榙e minimis鈥� exception. The full text of the decision is available below.
- (3.8.17)
Invitation to comment: Now closed
26 May 2017: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
Launch of merger inquiry
26 May 2017: The CMA announced the launch of its merger inquiry by notice to the parties.
- (26.5.17)
Contact
Please send written representations about any competition or public interest to:
Updates to this page
-
Full text of the decision published.
-
Clearance decision announced.
-
First published.